Background Probabilistic scores have been recently suggested to identify pneumonia caused by multidrugresistant (MDR) bacteria. The aim of the study was to validate both Aliberti and Shorr scores in predicting MDR pneumonia, comparing them with healthcare associated pneumonia (HCAP) classification. Methods Two independent European cohorts of consecutive patients hospitalised with pneumonia were prospectively evaluated in Barcelona, Spain (BC) and Edinburgh, UK (EC). Data on admission and during hospitalisation were collected. The predictive value of the three scores was explored for correctly indicating the presence of MDR pneumonia via a receiver-operating characteristic (ROC) curve. Results A total of 1591 patients in the BC and 1883 patients in the EC were enrolled. The prevalence of patients with MDR pathogen among those with isolated bacteria was 7.6% in the BC and 3.3% in the EC. The most common MDR pathogen found in both cohorts was MRSA, followed by MDR P aeruginosa. A significantly higher prevalence of MDR bacteria was found among patients in the intensive care unit (ICU). The two probabilistic scores, and particularly the Aliberti one, showed an area under the ROC curve higher than the HCAP classification in predicting MDR pneumonia, especially in the ICU. Conclusions Risk scores able to identify MDR pneumonia could help in developing strategies for antimicrobial stewardship.

Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia : a European perspective / S. Aliberti, C. Cilloniz, J.D. Chalmers, A.M. Zanaboni, R. Cosentini, P. Tarsia, A. Pesci, F. Blasi, A. Torres. - In: THORAX. - ISSN 0040-6376. - 68:11(2013), pp. 997-999. [10.1136/thoraxjnl-2013-203384]

Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia : a European perspective

S. Aliberti;A.M. Zanaboni;F. Blasi
;
2013

Abstract

Background Probabilistic scores have been recently suggested to identify pneumonia caused by multidrugresistant (MDR) bacteria. The aim of the study was to validate both Aliberti and Shorr scores in predicting MDR pneumonia, comparing them with healthcare associated pneumonia (HCAP) classification. Methods Two independent European cohorts of consecutive patients hospitalised with pneumonia were prospectively evaluated in Barcelona, Spain (BC) and Edinburgh, UK (EC). Data on admission and during hospitalisation were collected. The predictive value of the three scores was explored for correctly indicating the presence of MDR pneumonia via a receiver-operating characteristic (ROC) curve. Results A total of 1591 patients in the BC and 1883 patients in the EC were enrolled. The prevalence of patients with MDR pathogen among those with isolated bacteria was 7.6% in the BC and 3.3% in the EC. The most common MDR pathogen found in both cohorts was MRSA, followed by MDR P aeruginosa. A significantly higher prevalence of MDR bacteria was found among patients in the intensive care unit (ICU). The two probabilistic scores, and particularly the Aliberti one, showed an area under the ROC curve higher than the HCAP classification in predicting MDR pneumonia, especially in the ICU. Conclusions Risk scores able to identify MDR pneumonia could help in developing strategies for antimicrobial stewardship.
English
Settore MED/10 - Malattie dell'Apparato Respiratorio
Articolo
Esperti anonimi
2013
68
11
997
999
3
Pubblicato
Periodico con rilevanza internazionale
info:eu-repo/semantics/article
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia : a European perspective / S. Aliberti, C. Cilloniz, J.D. Chalmers, A.M. Zanaboni, R. Cosentini, P. Tarsia, A. Pesci, F. Blasi, A. Torres. - In: THORAX. - ISSN 0040-6376. - 68:11(2013), pp. 997-999. [10.1136/thoraxjnl-2013-203384]
none
Prodotti della ricerca::01 - Articolo su periodico
9
262
Article (author)
Periodico con Impact Factor
S. Aliberti, C. Cilloniz, J.D. Chalmers, A.M. Zanaboni, R. Cosentini, P. Tarsia, A. Pesci, F. Blasi, A. Torres
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/226624
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 117
  • ???jsp.display-item.citation.isi??? 101
social impact